Content continues after advertisement

Presurgical Pulmonary Imaging in Dogs with Soft Tissue Sarcoma

Andy H. Abbo, DVM, MS, DACVIM (Oncology), Veterinary Cancer Specialists of New England

Oncology

|October 2021

Sign in to Print/View PDF

In the Literature

Villedieu EJ, Petite AF, Godolphin JD, Bacon NJ. Prevalence of pulmonary nodules suggestive of metastasis at presentation in dogs with cutaneous or subcutaneous soft tissue sarcoma. J Am Vet Med Assoc. 2021;258(2):179-185.


FROM THE PAGE…

Nonvisceral soft tissue sarcomas (STSs) are often cured with aggressive local control (ie, surgery and/or radiation therapy). Tumor grade is the most important predictor for biological behavior and metastatic potential. Previously reported rates of metastasis range from 0% to 41%,1 and the rate of metastasis to the lungs increases with increased tumor grade. Staging is a standard and integral diagnostic step that should be performed before aggressive local control is applied. Standard staging should include thoracic imaging and can be performed with either CT or 3-view survey radiography of the thorax. CT is considered more sensitive than radiography and may detect lesions as small as 1 to 2 mm.2-4 Both procedures are considered low-risk, and discussion with pet owners should focus on the diagnostic value of each test before definitive therapy is started. 

The goals of this study were to investigate the prevalence of pulmonary nodules suggestive of metastasis in dogs (n = 146) with cutaneous or subcutaneous STS using either thoracic radiography or CT and to identify possible associations between prevalence and patient and tumor characteristics. This study only included patients with no previous thoracic imaging to reduce bias. Patients with visceral or more biologically aggressive sarcomas and those with no final histologic diagnosis of STS were excluded from the study.  

Results showed that the presence of pulmonary lesions suggestive of metastasis increased with tumor grade. Overall, nodules suggestive of metastasis were present in only 11.7% of dogs. Nodules consistent with metastatic disease were reported as grade 1 (6%), grade 2 (6%), and grade 3 (38%). These findings are comparable to the historically reported metastasis rate for STS in dogs. 

STS duration before presentation (>3 months vs <3 months) was a useful predictor of metastatic disease at diagnosis. Although the authors concluded that thoracic imaging is a low-yield test, it can detect pulmonary metastases and define other potential underlying thoracic abnormalities. Sarcoma tumor grade is typically determined after removal, rather than before surgery. 

In this author's opinion, thoracic imaging should be performed before definitive therapy in all cases of STS. CT may be reserved for lesions that have been present >3 months.


…TO YOUR PATIENTS

Key pearls to put into practice:

1

Staging with thoracic imaging is an important part of oncologic decision-making and may help to identify other underlying disease processes.

2

Tumor grade is the most important factor in determining the metastatic potential of nonvisceral STS.

3

Patients with nonvisceral STS present for >3 months are more likely to have metastatic disease. Thoracic CT may be reserved for large, rapidly growing, invasive lesions that have been present >3 months; thoracic radiography may be sufficient for screening in most cases of STS.

References

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2022 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy